The C500G alleles may affect expression of other genes in close proximity to CDKN2A. Both CDKN2B and the non-coding RNA designated ANRIL are included with CDKN2A in the susceptibility locus associated with glioma and other diseases [35], [36], [37], [38]. Here, CDKN2B-AS1 is linked to central nervous system cancer.